Table 3.

ORs of receiving anticancer drugs, palliative care or both given each covariate (two-level multivariate model considering LHA clustering)

Factor	Anticancer drugs	Palliative care	Anticancer drugs+palliative care
	OR (CI 95%)	OR (CI 95%)	OR (CI 95%)
Anticancer drugs within the last 30 days	–	0.90* (0.85 to 0.94)	–
Palliative care within the last 30 days	0.92* (0.87 to 0.97)	–	–
Haematologic tumour (ref. solid/metastatic)	2.15* (2.00 to 2.30)	0.52* (0.49 to 0.56)	1.03 (0.92 to 1.16)
Age (continuous, in year)	0.95* (0.95 to 0.95)	0.99* (0.99 to 0.99)	0.96* (0.96 to 0.96)
Hospital admission within the last 6 months	1.63* (1.55 to 1.72)	0.70* (0.67 to 0.72)	1.05 (0.98 to 1.14)
Surgery within the last 6 months	0.59* (0.52 to 0.67)	0.44* (0.39 to 0.49)	0.42*(0.33 to 0.54)
Aggressive tumour	0.88* (0.84 to 0.93)	1.12* (1.08 to 1.16)	0.84*(0.78 to 0.90)

*Significance at p<0.05.

LHA, Local Health Authorities.